Biotechs seek VC alternatives

From the Triangle Business Journal:

"With venture capitalists reluctant to pour their cash into unproved health remedies, young biotechnology companies increasingly are turning to alternative forms of financing - often forging partnerships or signing licensing arrangements with other firms. "